• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,618
    Total Members
    3,093
    Most Online
    Leet
    Newest Member
    Leet
    Joined
  • 0

    2011 William K. Warren, Jr. Prize for Excellence in Celiac Disease Research Recipient Announced


    Scott Adams
    Image Caption: Frits Koning, PhD, Leiden University Medical Center

    The Wm. K. Warren Medical Research Center for Celiac Disease at the University of California, San Diego is pleased to announce that the recipient of the 2011 William K. Warren, Jr. Prize for Excellence in Celiac Disease Research is Frits Koning, Ph.D.   Professor Koning has been head of the Immunochemistry Section in the Department of Immunohematology and Blood Transfusion of the Leiden University Medical Centre (LUMC), the Netherlands, since 1993. He is the chairman of the scientific advisory board of the LUMC and the CEO of the Dutch Celiac Disease Consortium (CDC), funded through a 11.7 million euro grant from the Dutch Government for the period 2004 - 2012. In the CDC, immunologists, geneticists, food specialists and medical doctors collaborate with industrial partners to develop practical solutions to improve the quality of life of patients with celiac disease.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    Frits Koning received his Ph.D. from the University of Leiden and continued with postdoctoral studies at the NIH, Bethesda, USA where he identified γδ T cell receptors expressed by dendritic epidermal T cells. Back in Leiden he set up his own group within the LUMC and continued his research on the characterization and functionality of γδ T cell receptors in humans. Simultaneously he started to investigate the molecular basis for autoimmune diseases by determining the peptide-binding motifs specific for disease associated HLA-molecules. This work led to the identification of a peptide binding motif specific for HLA-DQ2 and subsequent work identified gluten peptides that could bind to the celiac disease associated HLA-DQ molecules and the realization that many of such peptides require modification by the enzyme tissue transglutaminase to facilitate high affinity binding to either HLA-DQ2 or HLA-DQ8 and the initiation of gluten-specific T cell responses. This provided a molecular explanation for the association between these HLA-DQ molecules and the development of celiac disease. Based on these results studies have been carried out to determine how gluten proteins can be detoxified and thus made suitable for consumption by celiac disease patients.

    Presented annually by The William K. Warren Foundation, the $25,000 William K. Warren, Jr. Prize is awarded internationally to an individual or group who has made a significant contribution to the field of celiac disease research through basic, translational, or clinical research.  Professor Koning will be presented with the award on Friday, June 3 at the University of California, San Diego, at which time he will present the 2011 Warren Prize Lecture, “Celiac Disease: How Complicated Can It Get?” Details can be found on the Center website, at http://celiaccenter.ucsd.edu.

    0


    User Feedback

    Recommended Comments

    There are no comments to display.



    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    In 1994 I was diagnosed with celiac disease, which led me to create Celiac.com in 1995. I created this site for a single purpose: To help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives. Celiac.com was the first site on the Internet dedicated solely to celiac disease. In 1998 I founded The Gluten-Free Mall, Your Special Diet Superstore!, and I am the co-author of the book Cereal Killers, and founder and publisher of Journal of Gluten Sensitivity.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   15 Members, 1 Anonymous, 529 Guests (See full list)

  • Related Articles

    Scott Adams
    Celiac.com 03/30/2005 - The original one-stop shop on the Internet for wheat and gluten-free foods has underwritten a new Public Radio program on celiac disease called Gut Reaction. The one-hour program was produced by Richard L. Paul of rlpaulproductions, LLC, many Public Radio stations across the USA have already aired it, including WAMU in Washington, DC, WILL-FM in Champaign/Urbana, IL, WBE in Chicago, IL, WCPN-FM in Cleveland, OH, seventeen stations on the Minnesota Public Radio Network, and it is scheduled to air on many more stations in the future--including next weekend on WFUV in New York City. Several stations who aired it got such an overwhelmingly positive listener response that they have decided to air it multiple times.
    The touching documentary details the difficult real-life stories of several individuals who, after suffering for many years with severe, unexplained health problems, were finally diagnosed with celiac disease. Unfortunately their stories are not unique, and resemble many of those who have been affected by the disease. According to Scott Adams, Founder of The Gluten-Free Mall® and Celiac.com: We underwrote Gut Reaction with the aim of getting the word out about celiac disease to millions of people across the USA, including to those who are unaware that they have it--a full 1-in-133 Americans have celiac disease, but only 1-in-4,700 are ever diagnosed--which is not an acceptable ratio. Hopefully this program will have a positive impact on those who hear it, and will ultimately lead to the diagnosis and treatment of many people. It is also our hope that the program will lead to a better understanding of the disease among those who dont have it, so that it will be easier for those with it to maintain its only acceptable medical treatment--a 100% gluten-free diet for life.
    Mr. Adams emphasizes that: We believe that Public Radio is the perfect vehicle to deliver this important message about celiac disease to people across the USA, because its function is public service and education via quality, educational programming--and Gut Reaction is just that. He continues: You can help us to get Gut Reaction aired in your community by going to Celiac.com and following the steps listed there to contact the programming director at your local Public Radio station. He explained that Public Radio programming is decided on a station by station basis, and each stations program director decides which shows get aired on their station--so each person who contacts them can have a huge influence on which programs get chosen.
    About The Gluten-Free Mall®, Your Special Diet Superstore®:
    Since 1998 The Gluten-Free Mall® has provided online shopping for wheat and gluten-free foods for those on special diets due to celiac disease, wheat allergy or other health reasons, via their Internet site: www.glutenfreemall.com.

    Jefferson Adams
    Celiac.com 01/07/2013 - In a recent article for Mindbodygreen.com, James Maskell, calls celiac the "world's greatest disease."
    Why does he say this? Mainly because celiac disease cannot be cured or treated with pills or other standard methods. Because avoiding wheat, rye and barley is the only way to heal celiac-related damage to the gut, celiac disease helps drive home the importance of diet and nutrition in treating and preventing numerous other diseases.
    Think about it. Numerous diseases, even those like heart disease or diabetes, which often have strong associations with poor diet, lack of exercise, etc., are treated, if not cured, with medical procedures and pharmaceutical drugs.
    It is a rare medical reality for a treatable disease to resist drugs and external cures, and for the only effective treatment to be a permanent dietary change.
    In every case of celiac disease, the treatment and cure come solely from the patient taking responsibility to avoid gluten, and to eat food that promotes gut health. This reality alerts people to the fact that certain diseases can be ameliorated or even cured by lifestyle and diet changes.
    That is why Maskell calls celiac disease the greatest disease in the world.
    Forgetting for a moment the more extreme cases, and the benefits of some conventional treatments, think of how different treatments for other diseases might be if a change of diet was the only option.
    Imagine if dietary change was the only viable option for diet-related heart disease. How many people might nip it in its infancy and reverse or control their heart disease before it ever became severe enough to require drugs or surgery?
    Think how different the food landscape in America would be if doctors told patients with diet-related heart disease and diet-related pre-diabetes that a change of diet was the only option.
    When doctors have to tell patients that the only solution to their disease is a dietary shift, the doors open for "awareness of integrative or functional approaches to health."
    Given that many of the growing health epidemics (obesity, diabetes, metabolic syndrome, etc.) in America have strong dietary components, will celiac disease promote a greater awareness and stronger reliance on the role of diet in treating disease? We can only watch and hope. And, according to Maskell, if we are one of the several million Americans with celiac disease, we can count our blessings.
    Do you have celiac disease? Do you agree with John Maskell's view? What has celiac disease taught you about the relationship between diet and good health?
    Source:
    Mindbodygreen.com

    Jefferson Adams
    Celiac.com 06/12/2013 - Pregnant women with higher levels of issue transglutaminase (anti-tTG), an antibody common in people with celiac disease, at risk for low fetal and birth weight in their babies, according to a new study in Gastroenterology.
    A number of studies before this one have confirmed an association between celiac disease and poor growth fetus growth, but very little study had been done as to how the level of celiac disease might affect fetal growth, birth weight or birth outcome.
    In an effort to better understand how the level of celiac disease affects fetal growth, birth weight, and birth outcome, a team of researchers set out to assess the associations between levels of antibodies against tissue transglutaminase (anti-tTG, a celiac disease marker) and fetal growth and birth outcomes for pregnant women.
    The research team included J.C. Kiefte-de Jong, V.W. Jaddoe, A.G. Uitterlinden, E. A. Steegers, S.P. Willemsen, A. Hofman, H.Hooijkaas, and H.A. Moll of the Generation R Study Group at Erasmus University Medical Center in Rotterdam, The Netherlands.
    They conducted a population-based prospective birth cohort study of 7046 pregnant women. Serum samples were collected during the second trimester of pregnancy and analyzed for levels of anti-tTG.
    Based on these levels, they grouped each woman into groups of negative anti-tTG (≤0.79 U/mL; n = 6702), intermediate anti-tTG (0.8 to ≤6 U/mL; n = 308), or high anti-tTG individuals (over 6 U/mL; n = 36). They then collected data for fetal growth and birth outcomes from ultrasound measurements and medical records.
    The fetal growth data showed that, on average, fetuses of women in the positive anti-tTG group were 16 g lighter than those of women in the negative anti-tTG group (95% confidence interval [CI], -32 to -1 g) during the second trimester and weighed 74 g less (95% CI, -140 to -8 g) during the third trimester.
    The birth outcome data revealed that newborns of women in the intermediate and positive anti-tTG groups weighed 53 g (95% CI, -106 to -1 g) and 159 g (95% CI, -316 to -1 g) less at birth, respectively, than those of women in the negative anti-tTG group. Of mothers in the intermediate anti-tTG group, those with HLA-DQ2 or -DQ8 had reduced birth weights that were double those of mothers without HLA-DQ2 or -DQ8.
    This study led the researchers to conclude that levels of anti-tTG in pregnant women are inversely associated with fetal growth. The higher the anti-tTG in women, the lower the birth weights of their babies. So, women with the highest levels of anti-tTG (over 6 U/mL) saw the greatest reduction in birth weight of their babies.
    Also, women with intermediate levels of anti-tTG (0.8 to ≤6 U/mL) saw lower birth weights that were even further reduced if they carried the HLA-DQ2 and -DQ8 gene markers.
    Source:
    Gastroenterology. 2013 Apr;144(4):726-735.e2. doi: 10.1053/j.gastro.2013.01.003.

    Jefferson Adams
    Celiac.com 09/12/2013 - The most recent industry report by Research and Markets offers a comprehensive analysis of key players in the gluten-free product industry, major gluten-free product types and their sales channels, with commentary on developments and trends.
    The report also provides a detailed analysis on various phases of numerous aspects of the gluten-free products industry, along with the competitive strategies favored by major industry players.
    Among the reports insights: As large supermarkets and mass retailers offer more gluten-free products, gluten-free sales by health and natural food stores are declining.
    Over the last ten years, as millions of Americans have stopped consuming products containing gluten from wheat, barley, or rye, the market for gluten-free foods and other products has shifted, and many products once regarded as specialty or niche products are now regarded as regular grocery items.
    The report projects global gluten-free product market to reach $6.2 billion at a CAGR of 10.2% by 2018. The report also provides market details and analysis for North America, now the largest market for gluten-free products, and for Europe, which is expected to show significant growth in the market in the near future.
    Some of that growth is attributed to a steady stream of new gluten-free products in the market, offering additional nutrition, new ingredients or flavors.
    The also report projects increased demand countries such as U.K., Italy, U.S., Spain, Germany, Australia, Brazil, Canada, and India, among others.
    The full report is available for purchase at: Gluten-Free Products Market By Type (Bakery & Confectionery, Snacks, Breakfast Cereals, Baking Mixes & Flour, Meat & Poultry Products), Sales Channel (Natural & Conventional) & Geography — Global Trends & Forecasts To 2018

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.